Vaginal lactobacilli produce anti-inflammatory beta-carboline compounds.
Webber, C. A.; Glick, V. J.; Martin, M.; Kim, C.; Ahmad, M.; Simmons, L. E.; Bang, S.; Chao, M. C.; Howard, N. C.; Fortune, S. M.; Beura, L. K.; Lee, S. Y.; Clardy, J.; Kim, K. H.; Gopinath, S.
Show abstract
The vaginal microbiome is a lactobacilli-dominant, human-adapted community consistently found in people around the world. Presence of lactobacilli-dominant vaginal microbial communities, apart from Lactobacillus iners, is associated with reduced vaginal inflammation and reduced levels of pro-inflammatory cytokines. Loss of lactobacilli-dominance is associated with inflammatory conditions such as bacterial vaginosis. It remains unclear if health-associated lactobacilli actively promote the anti-inflammatory immune homeostasis of the vaginal mucosa and if so, by which mechanisms. We have identified that Lactobacillus crispatus, a key vaginal bacterial species, secretes a family of {beta}-carboline compounds with anti-inflammatory activity. These compounds suppress NF{kappa}B and interferon signaling downstream of multiple pattern recognition receptors in human macrophages and significantly dampen type I interferon receptor activation. Topical vaginal application of an anti-inflammatory {beta}-carboline compound, perlolyrine, was sufficient to significantly reduce vaginal inflammation in a mouse model of genital herpes infection. Together, we identify a key family of compounds by which vaginal lactobacilli mediate host immune homeostasis and could highlight a new therapeutic avenue for vaginal inflammation.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius. 94%
- Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity 94%
- Functional identification of soluble uric acid as an endogenous inhibitor of CD38 94%
Similar papers in this journal
- Targeting deubiquitinating enzymes (DUBs) and ubiquitin pathway modulators to enhance host defense against bacterial infections 94%
- A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases 94%
- Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans 93%
Similar papers in this journal
- Brevibacillin 2V, a novel antimicrobial lipopeptide with an exceptional low hemolytic activity 94%
- Computational Microbiome Pharmacology Analysis Elucidates the Anti-Cancer Potential of Vaginal Microbes and Metabolites 94%
- Membrane-Interactive Compounds from Pistacia lentiscus L. Thwart Pseudomonas aeruginosa Virulence 93%
Similar papers in this journal
- Quorum sensing peptidic inhibitor rescue host immune system eradication: a novel QS infectivity mechanism 95%
- More than just an Eagle Killer: The freshwater cyanobacterium Aetokthonos hydrillicola produces highly toxic dolastatin derivatives 93%
- Post-infection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.